{"id":"persantin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute coronary syndrome","Acute erosive gastritis","Acute nephropathy","Alcoholism","Anemia","Anemia due to enzyme deficiency","Atrioventricular block","Breastfeeding (mother)","Constrictive pericarditis","Cor pulmonale","Disease of liver","Factor II deficiency","Gastrointestinal hemorrhage","Gastrointestinal ulcer","Gout","Hemophilia","Hypercalcemia","Hypokalemia","Hypomagnesemia","Idiopathic hypertrophic subaortic stenosis","Kidney disease","Low blood pressure","Myocardial infarction","Myocarditis","Myxedema","Nasal polyp","Peptic ulcer","Poisoning by digitalis glycoside","Pregnancy, function","Restrictive cardiomyopathy","Reye's syndrome","Senile cardiac amyloidosis","Sick sinus syndrome","Sinus bradycardia","Thrombocytopenic disorder","Thrombotic thrombocytopenic purpura","Ventricular fibrillation","Vitamin K deficiency","Wolff-Parkinson-White pattern","von Willebrand disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Equilibrative nucleoside transporter 4, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2"},"_scrapedAt":"2026-03-28T04:43:44.873Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Atrial fibrillation","diseaseId":"atrial-fibrillation","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic heart failure","diseaseId":"chronic-heart-failure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Myocardial Perfusion Imaging Adjunct","diseaseId":"myocardial-perfusion-imaging-adjunct","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Platelet Aggregation Inhibition","diseaseId":"platelet-aggregation-inhibition","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of Cerebral Thrombosis","diseaseId":"prevention-of-cerebral-thrombosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07461545","phase":"NA","title":"Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS","status":"RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-02-04","conditions":"Cirrhosis, Splenectomy, Venous Thrombosis","enrollment":40},{"nctId":"NCT07422818","phase":"NA","title":"Non-invasive Evaluation of Patients With Angina and Non-obstructive Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-03","conditions":"ANOCA - Angina With Non-obstructive Coronary Arteries","enrollment":35},{"nctId":"NCT07199504","phase":"PHASE2, PHASE3","title":"A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yunfeng Xia","startDate":"2025-07-01","conditions":"Restless Leg Syndrome Due to Uraemia","enrollment":80},{"nctId":"NCT06983795","phase":"","title":"Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study","status":"NOT_YET_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-07","conditions":"Ischemic Stroke, Patent Foramen Ovale","enrollment":1000},{"nctId":"NCT06670768","phase":"NA","title":"Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTA","status":"RECRUITING","sponsor":"Semmelweis University","startDate":"2024-03-06","conditions":"Coronary Artery Disease, Coronary Computed Tomography Angiography, SPECT","enrollment":50},{"nctId":"NCT06899399","phase":"NA","title":"Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-10-18","conditions":"Asymptomatic Carotid Artery Stenosis","enrollment":982},{"nctId":"NCT04645550","phase":"PHASE4","title":"Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2020-11-22","conditions":"Cirrhosis, Splenectomy; Status, Venous Thrombosis","enrollment":120},{"nctId":"NCT04410328","phase":"PHASE3","title":"Aggrenox To Treat Acute Covid-19","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-10-21","conditions":"Covid19","enrollment":98},{"nctId":"NCT06824454","phase":"PHASE2","title":"Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2025-03","conditions":"Hypophosphatemia, Kidney Transplantation","enrollment":90},{"nctId":"NCT00129038","phase":"PHASE4","title":"Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2004-04-01","conditions":"Coronary Arteriosclerosis","enrollment":11},{"nctId":"NCT04666454","phase":"PHASE4","title":"BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2020-12-14","conditions":"Takotsubo Syndrome","enrollment":1000},{"nctId":"NCT05763862","phase":"NA","title":"Genotype Guided Antiplatelet Therapy in Ischemic Stroke","status":"RECRUITING","sponsor":"National Neuroscience Institute","startDate":"2023-04-24","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":350},{"nctId":"NCT06549582","phase":"NA","title":"Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients","status":"NOT_YET_RECRUITING","sponsor":"Yan Zhu","startDate":"2024-10","conditions":"Cerebral Infarction, Chinese Herbal Medicine, Clinical Trial","enrollment":160},{"nctId":"NCT06268470","phase":"PHASE2","title":"Antiplatelet Therapy in Chronic Urticaria","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2018-06-01","conditions":"Chronic Urticaria","enrollment":12},{"nctId":"NCT05304455","phase":"NA","title":"Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2022-04-01","conditions":"Cirrhosis, Splenectomy, Venous Thrombosis","enrollment":40},{"nctId":"NCT03015974","phase":"","title":"Registry of IgA Nephropathy in Chinese Children","status":"UNKNOWN","sponsor":"Peking University First Hospital","startDate":"2016-01","conditions":"IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment","enrollment":1200},{"nctId":"NCT05166876","phase":"PHASE2","title":"Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19","status":"TERMINATED","sponsor":"Clear Creek Bio, Inc.","startDate":"2022-02-01","conditions":"COVID-19","enrollment":26},{"nctId":"NCT06053021","phase":"NA","title":"Antiplatelet Therapy for AIS Patients With Thrombocytopenia","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-09-15","conditions":"Acute Ischemic Stroke, Thrombocytopenia","enrollment":1200},{"nctId":"NCT03354273","phase":"PHASE3","title":"An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2018-06-05","conditions":"Coronary Artery Disease (CAD)","enrollment":730},{"nctId":"NCT04424901","phase":"PHASE2","title":"Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19","status":"TERMINATED","sponsor":"UConn Health","startDate":"2020-05-03","conditions":"COVID-19 Pneumonia, Vascular Complications","enrollment":41},{"nctId":"NCT05637333","phase":"","title":"Sonazoid in Myocardial Perfusion Imaging","status":"WITHDRAWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2022-12-15","conditions":"Diagnostic Imaging, Myocardial Ischemia","enrollment":""},{"nctId":"NCT04387942","phase":"NA","title":"The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura","status":"COMPLETED","sponsor":"The First Hospital of Jilin University","startDate":"2020-06-14","conditions":"Purpura, Schoenlein-Henoch","enrollment":59},{"nctId":"NCT04391179","phase":"PHASE2","title":"Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2020-05-31","conditions":"COVID, Corona Virus Infection, Covid-19","enrollment":99},{"nctId":"NCT05081115","phase":"","title":"Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging","status":"RECRUITING","sponsor":"Fatebenefratelli Hospital","startDate":"2021-04-01","conditions":"Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy","enrollment":10000},{"nctId":"NCT01947959","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-12-22","conditions":"Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation","enrollment":665533},{"nctId":"NCT02468102","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-06-15","conditions":"Acute Coronary Syndrome, Venous Thrombosis, Pulmonary Embolism","enrollment":99999},{"nctId":"NCT01947985","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-02-01","conditions":"Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation","enrollment":208958},{"nctId":"NCT01947998","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-12-22","conditions":"Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation","enrollment":50299},{"nctId":"NCT02565693","phase":"PHASE2","title":"Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2014-09","conditions":"Cerebral Hemorrhage, Atrial Fibrillation","enrollment":101},{"nctId":"NCT02043535","phase":"NA","title":"CO2 as a Stress Agent for Perfusion Imaging","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2014-03-12","conditions":"Coronary Artery Disease","enrollment":20},{"nctId":"NCT02786134","phase":"NA","title":"Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2016-04","conditions":"Coronary Heart Disease, Metabolic Syndrome, Diabetes Mellitus","enrollment":50},{"nctId":"NCT01781611","phase":"NA","title":"Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)","status":"TERMINATED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2013-02","conditions":"Systemic Lupus Erythematosus","enrollment":18},{"nctId":"NCT00738894","phase":"NA","title":"GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients","status":"COMPLETED","sponsor":"W.L.Gore & Associates","startDate":"2008-12-10","conditions":"Stroke, Transient Ischemic Attack","enrollment":664},{"nctId":"NCT04572373","phase":"","title":"Supplements SMOF in TPN for Liver Transplantation Recipients","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2012-01-01","conditions":"Liver Transplantation, Total Parenteral Nutrition, End-stage Liver Disease","enrollment":54},{"nctId":"NCT00349973","phase":"NA","title":"Clinical Trial of Dipyridamole in Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2001-05","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":29},{"nctId":"NCT03841383","phase":"","title":"Association Between Coronary Flow Reserve and BH4 Levels in High CV Risk","status":"COMPLETED","sponsor":"IRCCS San Raffaele","startDate":"2017-06-06","conditions":"Hypertension,Essential","enrollment":55},{"nctId":"NCT00760708","phase":"","title":"Circulating Adenosine Levels Before and After Intravenous (IV) Persantine","status":"TERMINATED","sponsor":"UConn Health","startDate":"2005-09","conditions":"Ischemia, Coronary Disease","enrollment":221},{"nctId":"NCT02121756","phase":"PHASE1, PHASE2","title":"Dipyridamole for Immune Activation in HIV","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2014-07","conditions":"HIV Infection","enrollment":40},{"nctId":"NCT02247414","phase":"PHASE4","title":"Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2014-09","conditions":"Cirrhosis, Hypertension, Status;Splenectomy","enrollment":124},{"nctId":"NCT00465270","phase":"NA","title":"Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2003-08","conditions":"Cryptogenic Stroke","enrollment":980},{"nctId":"NCT02238444","phase":"PHASE4","title":"Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy","status":"UNKNOWN","sponsor":"Yangzhou University","startDate":"2014-09-01","conditions":"Cirrhosis, Hypertension, Venous Thrombosis","enrollment":60},{"nctId":"NCT03688815","phase":"","title":"Dipyridamole Induced Ischemia and Biomarkers","status":"COMPLETED","sponsor":"University of Pecs","startDate":"2009-01-01","conditions":"Ischemic Heart Disease, Ischemic Attack","enrollment":50},{"nctId":"NCT03591471","phase":"PHASE1, PHASE2","title":"Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment","status":"UNKNOWN","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2014-09","conditions":"Henoch-Schönlein Purpura Nephritis","enrollment":500},{"nctId":"NCT01661322","phase":"PHASE3","title":"Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke","status":"TERMINATED","sponsor":"University of Nottingham","startDate":"2009-04","conditions":"Stroke","enrollment":3096},{"nctId":"NCT00763009","phase":"PHASE4","title":"Persantine: Variation in Response Trial","status":"TERMINATED","sponsor":"UConn Health","startDate":"2002-09","conditions":"Coronary Artery Disease","enrollment":8},{"nctId":"NCT03084562","phase":"","title":"Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-05-03","conditions":"Myocardial Perfusion Imaging","enrollment":300},{"nctId":"NCT01690884","phase":"PHASE1","title":"Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2012-08","conditions":"Coronary Artery Disease","enrollment":28},{"nctId":"NCT00562289","phase":"PHASE3","title":"Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-12","conditions":"Ischemic Stroke, Patent Foramen Ovale, Atrial Septal Aneurysm","enrollment":664},{"nctId":"NCT00223717","phase":"PHASE1","title":"Treatment of Supine Hypertension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2001-01","conditions":"Hypertension","enrollment":152},{"nctId":"NCT00067119","phase":"PHASE3","title":"Aggrenox Prevention of Access Stenosis","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2003-01-01","conditions":"Kidney Failure","enrollment":649},{"nctId":"NCT00906035","phase":"NA","title":"The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2002-09","conditions":"Peripheral Arterial Disease","enrollment":25},{"nctId":"NCT03150342","phase":"","title":"Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging","status":"UNKNOWN","sponsor":"Far Eastern Memorial Hospital","startDate":"2017-05-08","conditions":"Hypertrophic Cardiomyopathy, Myocardial Perfusion Imaging","enrollment":100},{"nctId":"NCT01520025","phase":"PHASE4","title":"Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2011-12","conditions":"Myocardial Ischemia","enrollment":18},{"nctId":"NCT03040700","phase":"NA","title":"Follow-up of Patients With Multivessel Coronary Artery Disease After CABG","status":"UNKNOWN","sponsor":"Ministry of Health, Brazil","startDate":"2014-11","conditions":"Coronary (Artery); Disease","enrollment":600},{"nctId":"NCT01397357","phase":"","title":"Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease","status":"COMPLETED","sponsor":"Ettore Sansavini Health Science Foundation","startDate":"2011-07","conditions":"Myocardial Ischemia","enrollment":146},{"nctId":"NCT00560079","phase":"PHASE4","title":"Efficacy of Allopurinol and Dypiridamole in Acute Mania","status":"COMPLETED","sponsor":"Hospital Espirita de Porto Alegre","startDate":"2003-11","conditions":"Mania","enrollment":180},{"nctId":"NCT02782260","phase":"PHASE2","title":"Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium","status":"UNKNOWN","sponsor":"Ariel University","startDate":"2016-07","conditions":"Dry Eye Syndromes, Pterygium","enrollment":40},{"nctId":"NCT01412827","phase":"NA","title":"Accuracy of Half of the Usual Radiotracer Dose in SPECT","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2010-04","conditions":"Coronary Artery Disease","enrollment":18},{"nctId":"NCT02630862","phase":"NA","title":"Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2010-09","conditions":"Carotid Stenosis, Cardiovascular Disease, Atherosclerosis","enrollment":240},{"nctId":"NCT00767663","phase":"PHASE4","title":"Persantin Preceding Elective PCI","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2008-10","conditions":"Coronary Heart Disease, Percutaneous Transluminal Coronary Angioplasty, Atherosclerosis","enrollment":30},{"nctId":"NCT02500420","phase":"NA","title":"Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography","status":"UNKNOWN","sponsor":"University Hospital, Montpellier","startDate":"2014-12","conditions":"Hypertrophic Cardiomyopathy","enrollment":25},{"nctId":"NCT00238667","phase":"PHASE3","title":"To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2005-11","conditions":"Cervical Artery Dissection, Carotid Artery Dissection, Vertebral Artery Dissection","enrollment":250},{"nctId":"NCT01179230","phase":"","title":"Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2005-01","conditions":"Coronary Artery Disease, Myocardial Ischemia, Heart Disease","enrollment":136},{"nctId":"NCT02278302","phase":"PHASE1","title":"Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1999-08","conditions":"Healthy","enrollment":56},{"nctId":"NCT02273518","phase":"PHASE1","title":"Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-04","conditions":"Healthy","enrollment":18},{"nctId":"NCT02273531","phase":"PHASE1","title":"Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2004-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT02273544","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2002-09","conditions":"Healthy","enrollment":16},{"nctId":"NCT02273479","phase":"PHASE1","title":"Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1999-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT02273505","phase":"PHASE1","title":"Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-04","conditions":"Healthy","enrollment":20},{"nctId":"NCT02273557","phase":"PHASE1","title":"Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-01","conditions":"Healthy","enrollment":19},{"nctId":"NCT02268773","phase":"PHASE1","title":"Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-01","conditions":"Healthy","enrollment":27},{"nctId":"NCT02262793","phase":"PHASE1","title":"Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2004-05","conditions":"Healthy","enrollment":24},{"nctId":"NCT02259998","phase":"PHASE1","title":"Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-10","conditions":"Healthy","enrollment":30},{"nctId":"NCT02251184","phase":"PHASE4","title":"Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-10","conditions":"Healthy","enrollment":31},{"nctId":"NCT02226926","phase":"PHASE1","title":"Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-07","conditions":"Healthy","enrollment":15},{"nctId":"NCT00747214","phase":"PHASE2","title":"A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA","status":"COMPLETED","sponsor":"Zalicus","startDate":"2004-11","conditions":"Rheumatoid Arthritis","enrollment":59},{"nctId":"NCT01369745","phase":"PHASE2","title":"A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Zalicus","startDate":"2011-06","conditions":"Rheumatoid Arthritis","enrollment":294},{"nctId":"NCT00153062","phase":"PHASE4","title":"PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-08","conditions":"Stroke","enrollment":20332},{"nctId":"NCT00551707","phase":"PHASE2","title":"Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Zalicus","startDate":"2007-10","conditions":"Rheumatoid Arthritis","enrollment":51},{"nctId":"NCT00521989","phase":"PHASE2","title":"CRx-102 Osteoarthritis Multicenter Evaluation Trial","status":"TERMINATED","sponsor":"Zalicus","startDate":"2007-08","conditions":"Knee Osteoarthritis","enrollment":279},{"nctId":"NCT00562588","phase":"PHASE4","title":"EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2007-07","conditions":"Cerebrovascular Accident","enrollment":551},{"nctId":"NCT00949520","phase":"NA","title":"Stress Multidetector Computed Tomography (MDCT) an New Diagnostic Tool for Myocardial Disease","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2009-07","conditions":"Coronary Artery Lesion","enrollment":17},{"nctId":"NCT00311402","phase":"PHASE3","title":"JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-04","conditions":"Cerebrovascular Accident","enrollment":1295},{"nctId":"NCT01303445","phase":"PHASE1","title":"Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2011-03","conditions":"Healthy","enrollment":60},{"nctId":"NCT00000527","phase":"PHASE2","title":"Recurrent Carotid Stenosis","status":"COMPLETED","sponsor":"Emory University","startDate":"1986-08","conditions":"Cardiovascular Diseases, Carotid Stenosis, Cerebrovascular Disorders","enrollment":""},{"nctId":"NCT00000496","phase":"PHASE3","title":"Platelet Drug Trial in Coronary Disease Progression","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1979-12","conditions":"Cardiovascular Diseases, Coronary Disease, Heart Diseases","enrollment":""},{"nctId":"NCT00000510","phase":"PHASE3","title":"Platelet-Inhibitor Drug Trial in Coronary Angioplasty","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1983-09","conditions":"Angina Pectoris, Cardiovascular Diseases, Coronary Disease","enrollment":""},{"nctId":"NCT01993303","phase":"","title":"Direct Comparison of 2D Cardiac PET With 3D Cardiac PET","status":"COMPLETED","sponsor":"Cardiovascular Imaging Technologies","startDate":"2004-01","conditions":"Coronary Artery Disease","enrollment":19},{"nctId":"NCT00002487","phase":"PHASE2","title":"Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer","status":"UNKNOWN","sponsor":"Ottawa Regional Cancer Centre","startDate":"1991-07","conditions":"Ovarian Cancer","enrollment":""},{"nctId":"NCT00276146","phase":"PHASE2","title":"Dipyridamole/Magnesium To Improve Sickle Cell Hydration","status":"WITHDRAWN","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2005-05","conditions":"Anemia, Sickle Cell","enrollment":""},{"nctId":"NCT01613755","phase":"PHASE4","title":"Metformin-Dipyridamole Interaction Trial","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2012-04","conditions":"Diabetes","enrollment":18},{"nctId":"NCT01021618","phase":"NA","title":"Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2010-01","conditions":"Coronary Artery Disease, Myocardial Ischemia","enrollment":140},{"nctId":"NCT01295567","phase":"PHASE4","title":"Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2009-12","conditions":"Cardiovascular Disease, Ischemic Heart Disease","enrollment":95},{"nctId":"NCT00003018","phase":"PHASE2","title":"S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1997-09","conditions":"Pancreatic Cancer","enrollment":54},{"nctId":"NCT01612377","phase":"PHASE2","title":"Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Zalicus","startDate":"2012-03","conditions":"Rheumatoid Arthritis","enrollment":18},{"nctId":"NCT01593644","phase":"PHASE2","title":"Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler","status":"UNKNOWN","sponsor":"Adenobio N.V","startDate":"2011-06","conditions":"Ischemic Heart Disease","enrollment":75},{"nctId":"NCT00808314","phase":"PHASE4","title":"Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress","status":"UNKNOWN","sponsor":"Cardiovascular Imaging Technologies","startDate":"2008-12","conditions":"Coronary Artery Disease","enrollment":32},{"nctId":"NCT01280071","phase":"NA","title":"Adenosine Activity in Producing Venoarteriolar Reflexes","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"","conditions":"Venoarteriolar Reflex","enrollment":""},{"nctId":"NCT01091571","phase":"PHASE4","title":"The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2010-03","conditions":"Endotoxemia","enrollment":30},{"nctId":"NCT00960817","phase":"EARLY_PHASE1","title":"\"Normal Coronary Artery\" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up","status":"UNKNOWN","sponsor":"Hillel Yaffe Medical Center","startDate":"","conditions":"Coronary Angiography","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":248,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Persantin","genericName":"Persantin","companyName":"Boehringer Ingelheim","companyId":"boehringer-ingelheim","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Persantine, also known as Dipyridamole, is a small molecule inhibitor of the equilibrative nucleoside transporter 1. It is used to prevent blood clot formation and has been studied in various conditions, including kidney transplantation, cerebrovascular accidents, and hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}